Zydus and Lupin Partner to Launch Semaglutide Injection in India for Diabetes & Weight Loss
Ahmedabad, March 17, 2026: Pharma companies Zydus Lifesciences Limited and Lupin Limited have signed a licensing and supply agreement to co-market an innovative Semaglutide Injection in India, aimed at treating diabetes and obesity. Under the agreement, Zydus will manufacture the product, while Lupin will get semi-exclusive rights to co-market it in India. The drug will … Read more